Pick one of the followings
*Some genes may be words of complete meaning. In any case, if present, they are relevant key words.
Legend:
| *** | p-value <= 0.001 |
| ** | p-value <= 0.01 |
| * | p-value <= 0.05 |
| n.s. | not significant |
|
Top Ranked Genes, Molecules or Short Names*
|
Top Ranked Key Phrases
Multiparametric magnetic resonance imaging mpmri ***
 Prostate specific membrane antigen psma ***
Metastatic castration resistant prostate cancer ***
Castration resistant prostate cancer crpc ***
Prostate specific antigen psa level ***
Castration resistant prostate cancer ***
Prostate specific antigen psa ***
Intensity modulated radiation therapy ***
Androgen deprivation therapy adt ***
Prostate cancer cell lines ***
Prostate cancer specific mortality ***
Benign prostatic hyperplasia bph ***
High risk prostate cancer ***
Intermediate risk prostate cancer ***
Magnetic resonance imaging ***
Low risk prostate cancer ***
Prostate cancer pca cells ***
Progression free survival pfs ***
Prostate specific antigen ***
Prostate cancer pca patients ***
Androgen deprivation therapy ***
Benign prostatic hyperplasia **
Digital rectal examination **
Prostate imaging reporting **
External beam radiotherapy **
Localized prostate cancer **
Metastatic prostate cancer **
Advanced prostate cancer **
Shared decision making **
Radical prostatectomy rp **
Prostate cancer survivors **
Prostate cancer screening **
Underwent radical prostatectomy **
Aggressive prostate cancer **
Prostate cancer tissues **
Negative predictive value *
Prostate cancer progression *
Prostate cancer treatment *
Prostate cancer detection *
Prostate cancer incidence *
Prostate cancer diagnosis *
Prostate cancer patients *
Biochemical recurrence bcr *
Potential therapeutic target *
Second leading cause n.s.
95% confidence interval ci 0 n.s.
95% confidence interval ci n.s.
|
Top Ranked Mesh Terms
Bone density conservation agents *
Digital rectal examination *
Robotic surgical procedures *
Diffusion magnetic resonance imaging *
Proto-oncogene proteins c-akt *
Prostatic neoplasms castration-resistant n.s.
Xenograft model antitumor assays n.s.
Molecular targeted therapy n.s.
Drug resistance neoplasm n.s.
Prostate-specific antigen n.s.
Diagnosis differential n.s.
Alkaline phosphatase n.s.
Postoperative complications n.s.
L-lactate dehydrogenase n.s.
Predictive value of tests n.s.
Tomography x-ray computed n.s.
Epithelial-mesenchymal transition n.s.
Magnetic resonance imaging n.s.
Retrospective studies n.s.
Disease-free survival n.s.
Immunohistochemistry n.s.
Radiotherapy planning computer-assisted n.s.
Case-control studies n.s.
Tissue array analysis n.s.
Androgen receptor antagonists n.s.
Gene expression regulation neoplastic n.s.
Signal-to-noise ratio n.s.
Equipment and supplies hospital n.s.
Promoter regions genetic n.s.
Lower urinary tract symptoms n.s.
Patient reported outcome measures n.s.
Practice guidelines as topic n.s.
Glucose transporter type 1 n.s.
Myeloid-lymphoid leukemia protein n.s.
Health services accessibility n.s.
Drug-related side effects and adverse reactions n.s.
Epidemiologic methods n.s.
Core binding factor alpha 1 subunit n.s.
Matrix attachment region binding proteins n.s.
Epithelial cell adhesion molecule n.s.
Tacrolimus binding proteins n.s.
Radiopharmaceuticals n.s.
Receptors somatostatin n.s.
Ataxia telangiectasia mutated proteins n.s.
Neuroendocrine tumors n.s.
Neuroendocrine cells n.s.
Stat3 transcription factor n.s.
Bridged-ring compounds n.s.
|
Top Ranked Mesh Terms (Symptoms)
Postoperative complications n.s.
Lower urinary tract symptoms n.s.
Neoplastic cells circulating n.s.
Neoplasm recurrence local n.s.
Neoplasm invasiveness n.s.
Genetic predisposition to disease n.s.
|